Where does Vigmed AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vigmed AB ranks #30,558 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vigmed AB hold?

Vigmed AB holds 9 US utility patents granted between 2016 and 2021, spanning 5 technology areas.

What is Vigmed AB's Innovation Score?

Vigmed AB has an Innovation Score of 27.0 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vigmed AB's patent grant rate increasing or decreasing?

Vigmed AB's recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Vigmed AB's patents?

Vigmed AB's patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vigmed AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Vigmed AB

Q: What technology areas does Vigmed AB focus on?

Vigmed AB's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 8 patents, ranking #855 of 3,490 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vigmed ranks #30,558 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.

#30,558
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (27.0/100): 18.6
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30558 · Foreign Corporation #30,558 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #30,558/49,997
PHOTO-FINISH Veritas US IP Holdings
CPC-NARROW A61M · 5 areas
INNOV-THIN 27.0/100
CLAIMS-RICH 18.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Veritas US IP Holdings LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vigmed’s 27.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (30%) Velocity 0.0 pts (0%) Breadth 7.9 pts (29%) Claim depth 11.1 pts (41%)

Qualcomm Incorporated · highest

85
Vigmed AB · this assignee

27
3D Lighting… · lowest

7

What this shows Vigmed's Innovation Score is 27.0/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vigmed?

Each dot is one of Vigmed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vigmed’s own 18.6 claims/patent is ABOVE the 17.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Vigmed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vigmed's grants concentrate

Vigmed AB is a focused PatentsView assignee: 5 CPC subclasses with 88.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2018. By volume, Vigmed sits between Veritas US IP Holdings LLC and Vivo Communication Co., Ltd..

Veritas US IP Hol…

9
Vescel

9
VGP Ipco

9
Viconic Sporting

9
Virox

9
Visic

9
Vision Engineering

9
Vivo Communication

9
Vigmed AB ◀

9

What this shows Vigmed holds 9 patents at rank #30,505, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vigmed

By rank, the assignees closest to #30,505 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Vigmed's primary technology class.

Vigmed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Vigmed AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	22.2%
2017	3	33.3%
2018	1	11.1%
2019	1	11.1%
2020	1	11.1%
2021	1	11.1%

Which technologies does Vigmed AB patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

Y10T - Technical Subjects Covered BY Former US Classification 1

F41H - ARMOUR; Armoured TURRETS; Armoured OR Armed VEHICLES; Means OF Attack OR Defence, e.g. Camouflage, IN General 1

A45F - Travelling OR Camp EQUIPMENT: Sacks OR Packs Carried ON THE Body 1

A44B - Buttons, Pins, Buckles, Slide Fasteners, OR THE Like 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vigmed AB's patent record in context - here's where to go next.

Vigmed AB's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 88.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #30,558 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vigmed AB against Veritas US IP Holdings LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.